Nathan J. W. Wu

Nathan J. W. Wu

Auto-generated profile, based on publicly available information

Nathan J. W. Wu

Institute for Bioengineering, School of Engineering, University of Edinburgh, Edinburgh, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
MAMatthew Aquilina
Matthew Aquilina
NWNathan J. W. Wu
Nathan J. W. Wu
KKKiros Kwan
Kiros Kwan
FBFilip Bušić
Filip Bušić
JDJames Dodd
James Dodd
KDKatherine Dunn
Katherine Dunn
Gel electrophoresis is a ubiquitous laboratory method for the separation and semi-quantitative analysis of biomolecules. However, gel image analysis principles have barely advanced for decades, in stark contrast to other fields where AI has revolutionised data processing. Here, we show that an AI-based system can automatically identify gel bands in seconds for a wide range of experimental conditions, surpassing the capabilities of current software in both ease-of-use and versatility. We use a dataset containing 500+ images of manually-labelled gels to train various U-Nets to accurately identify bands through segmentation, i.e. classifying pixels as ‘band’ or ‘background’. When applied to gel electrophoresis data from other laboratories, our system generates results that quantitatively match those of the original authors. We have publicly released our models through GelGenie, an open-source application that allows users to extract bands from gel images on their own devices, with no expert knowledge or experience required.

18 March 2022 in IEEE Reviews in Biomedical Engineering
Verified
Journal Article
Open access
NWNathan J. W. Wu
Nathan J. W. Wu
MAMatthew Aquilina
Matthew Aquilina
BQBin-Zhi Qian
Bin-Zhi Qian
RLRemco Loos
Remco Loos
IGInes Gonzalez-Garcia
Ines Gonzalez-Garcia
KDKatherine Dunn
Katherine Dunn
Technologies for quantifying circulating tumour DNA (ctDNA) in liquid biopsies could enable real-time measurements of cancer progression, profoundly impacting patient care. Sequencing methods can be too complex and time-consuming for regular point-of-care monitoring, but nanotechnology offers an alternative, harnessing the unique properties of objects tens to hundreds of nanometres in size. This systematic review was performed to identify all examples of nanotechnology-based ctDNA detection and assess their potential for clinical use. Google Scholar, PubMed, Web of Science, Google Patents, Espacenet and Embase/MEDLINE were searched up to 23rd March 2021. The review identified nanotechnology-based methods for ctDNA detection for which quantitative measures (e.g. limit of detection, LOD) were reported and biologically relevant samples were used. The pre-defined inclusion criteria were met by 66 records. LODs ranged from 10 zM to 50nM. 25 records presented an LOD of 10fM or below. Nanotechnology-based approaches could provide the basis for the next wave of advances in ctDNA diagnostics, enabling analysis at the point-of-care, but none are currently used clinically. Further work is needed in development and validation; trade-offs are expected between different performance measures e.g. number of sequences detected and time to result.

18 February 2026 in Biochemical Society Transactions
Verified
Journal Article
Open access
Anitha DevadossAnitha Devadoss
Anitha Devadoss
MFMichael R. Furness
Michael R. Furness
NWNathan J.W. Wu
Nathan J.W. Wu
OOOlga Oikonomidou
Olga Oikonomidou
MKMaïwenn Kersaudy-Kerhoas
Maïwenn Kersaudy-Kerhoas
NLNick Leslie
Nick Leslie
Better biomarker analysis technologies can provide improvements in the detection, characterisation and monitoring of cancer and less invasive sampling of blood and other body fluids can improve acceptability and affordability. Here, we discuss these technologies with a specific focus on recent advances in electrochemical sensors, specifically for the analysis of extracellular vesicles (EVs). Widely used biomarker tests with relatively high sensitivity (e.g. ELISAs) are limited by their cost, storage requirements and shelf-life, and ease of use away from centralised facilities. Moreover, their limits of detection (most commonly in the nanomolar to picomolar, with new technologies pushing into the femtomolar range) remain challenged by low abundance biomarkers. Here, we discuss how electrochemical sensor platforms, although often requiring more effort to adapt for new analytes, can provide high sensitivity and direct quantitation at low cost. These platforms are also often simpler to use away from testing facilities. Additionally, we explore how EVs, by protecting nucleic acid and protein cargos from degradation, may facilitate the collective enrichment from blood samples of multiple tumour-derived biomarkers. Continued progress in analysis technologies, alongside a deeper understanding of biomarker biology and clinical value, holds the potential to improve outcomes for the increasing numbers of individuals diagnosed with cancer.

6 September 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MAMatthew Aquilina
Matthew Aquilina
NWNathan J.W. Wu
Nathan J.W. Wu
KKKiros Kwan
Kiros Kwan
FBFilip Bušić
Filip Bušić
JDJames Dodd
James Dodd
KDKatherine Dunn
Katherine Dunn
Gel electrophoresis is a ubiquitous laboratory method for the separation and semi-quantitative analysis of biomolecules. However, gel image analysis principles have barely advanced for decades, in stark contrast to other fields where AI has revolutionised data processing. Here, we show that an AI-based system can automatically identify gel bands in seconds for a wide range of experimental conditions, far surpassing the capabilities of current software. We used a dataset containing 500+ images of manually-labelled gels to train various U-Nets to accurately identify bands through segmentation, i.e. classifying pixels as ‘band’ or ‘background’. When applied to gel electrophoresis data from other laboratories, our system generated results that quantitatively matched those of the original authors. We have publicly released our models through GelGenie, an open-source application that allows users to extract bands from gel images on their own devices, with no expert knowledge or experience required.